Clinical Trial Update: Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension [NA]

View source ↗

Summary

A clinical trial is evaluating royal jelly to reduce inflammation and oxidative stress in patients with hypertension and cardiovascular disease; recruitment is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypertension

Drugs mentioned

• Royal Jelly

Snippet

Sponsor: Universidade Federal Fluminense | Conditions: Hypertension, Cardiovascular Diseases (CVD) | NA | Status: RECRUITING